<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2017-11-36-42</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-997</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>ПРИМЕНЕНИЕ ШКАЛЫ GRACE ПРИ ОСТРОМ КОРОНАРНОМ СИНДРОМЕ В СОЧЕТАНИИ С ПОЧЕЧНОЙ ДИСФУНКЦИЕЙ</article-title><trans-title-group xml:lang="en"><trans-title>IMPLEMENTATION OF THE GRACE SCORE IN ACUTE CORONARY SYNDROME WITH RENAL DYSFUNCTION</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0954-9270</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зыков</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zykov</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зыков Михаил Валерьевич — кандидат медицинских наук, научный сотрудник лаборатории патофизиологии мультифокального атеросклероза.</p></bio><bio xml:lang="en"><p>Kemerovo</p></bio><email xlink:type="simple">mvz83@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кашталап</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kashtalap</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кашталап Василий Васильевич — доктор медицинских наук, зав. лабораторией патофизиологии мультифокального атеросклероза, доцент кафедры кардиологии и сердечно-сосудистой хирургии</p></bio><email xlink:type="simple">v_kash@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Быкова</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Bykova</surname><given-names>I. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Быкова Ирина Сергеевна — кандидат медицинских наук, научный сотрудник лаборатории патофизиологии мультифокального атеросклероза.</p><p>Кемерово</p></bio><bio xml:lang="en"><p>Kemerovo</p></bio><email xlink:type="simple">squierrel2007@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Груздева</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gruzdeva</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Груздева Ольга Викторовна — доктор медицинских наук, зав. клинико-диагностической лабораторией, лабораторией исследования гемостаза.</p><p>Кемерово</p></bio><bio xml:lang="en"><p>Kemerovo</p></bio><email xlink:type="simple">gruzov@kemcardio.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каретникова</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Karetnikova</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каретникова Виктория Николаевна — доктор медицинских наук, зав. лабораторией патологии кровообращения, профессор кафедры кардиологии и сердечно-сосудистой хирургии</p></bio><email xlink:type="simple">Tori1071@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барбараш</surname><given-names>О. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Barbarash</surname><given-names>О. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Барбараш Ольга Леонидовна — доктор медицинских наук, профессор, директор</p></bio><email xlink:type="simple">olb61@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute for Complex Issues of Cardiovascular Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБНУ Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний; ФГБОУ ВО Кемеровский государственный медицинский университет Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute for Complex Issues of Cardiovascular Diseases; Kemerovo State Medical University of the Ministry of Health</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>09</day><month>12</month><year>2017</year></pub-date><volume>0</volume><issue>11</issue><fpage>36</fpage><lpage>42</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зыков М.В., Кашталап В.В., Быкова И.С., Груздева О.В., Каретникова В.Н., Барбараш О.Л., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Зыков М.В., Кашталап В.В., Быкова И.С., Груздева О.В., Каретникова В.Н., Барбараш О.Л.</copyright-holder><copyright-holder xml:lang="en">Zykov M.V., Kashtalap V.V., Bykova I.S., Gruzdeva O.V., Karetnikova V.N., Barbarash О.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/997">https://russjcardiol.elpub.ru/jour/article/view/997</self-uri><abstract><sec><title>Цель</title><p>Цель. Выявить наиболее значимые факторы кардиоваскулярного риска у больных с острым коронарным синдромом (ОКС) и почечной дисфункцией (ПД), перенесших чрескожное коронарное вмешательство (ЧКВ).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В исследование включено 206 пациентов. Критерием ПД явилось снижение скорости клубочковой фильтрации (СКФ) &lt;60 мл/ мин/1,73 м2, рассчитанного по формуле CKD-EPI (2011) на основании концентрации креатинина крови при поступлении стационар. Госпитальная летальность составила 13,1% (n=27). Годовая летальность от любых причин составила 15,5% (n=32), 3-х летняя — 21,8% (n=45).</p></sec><sec><title>Результаты</title><p>Результаты. Однофакторный анализ установил, что наиболее значимыми факторами госпитальной и отдаленной летальности у больных с ОКС и ПД, перенесших ЧКВ, явились застойная сердечная недостаточность, инсульт и инфаркт миокарда в анамнезе, острая сердечная недостаточность (ОСН), гипергликемия, выраженная систолическая дисфункция миокарда, тахикардия и гипотония при поступлении в стационар, многососудистое поражение коронарных артерий, а также острое повреждение почек (ОПП), развившееся в течение госпитализации (критерии критериям RIFLE и AKIN). Пошаговый отбор в регрессии Кокса показал, что факторами, наличие которых связано с повышением частоты госпитальной летальности, явились инсульт в анамнезе, ОСН на момент поступления, а также развитие ОПП в течение госпитализации. С-статистика полученной модели составила 0,82, что значительно больше, чем у шкалы GRACE 2,0-0,74. При проведении анализа долгосрочной выживаемости Кокса выявлено, что наличие в анамнезе инсульта и инфаркта миокарда, а также ОСН при поступлении в стационар и ОПП независимо от других факторов связаны с повышением частоты смертельных исходов в течение одного и трех лет наблюдения. При этом площадь под ROC-кривыми собственных моделей риска составила 0,84 и 0,76, соответственно, для года и трех лет. У шкалы GRACE 2,0 данный показатель достоверно ниже — 0,78 и 0,69, соответственно.</p></sec><sec><title>Заключение</title><p>Заключение. Приведенные результаты свидетельствуют о том, что у больных ОКС и исходной ПД необходимо учитывать дополнительные факторы при стратификации риска после ЧКВ, а разработанные новые модели оказались достоверно лучше шкалы GRACE.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To investigate on the most significant predictors of cardiovascular risk in acute coronary (ACS) and kidney dysfunction (KD) patients, underwent percutaneous coronary intervention (PCI).</p></sec><sec><title>Material and methods</title><p>Material and methods. Totally, 206 patients included into the study. As the criteria of KD glomerular filtration rate below 60 mL/min/1,73 m2  was taken, by CKD-EPI (2011) based on the blood creatinine concentration at hospitalization. In-hospital mortality was 13,1% (n=27). All-cause annual mortality was 15,5% (n=32), 3-year mortality — 21,8% (n=45).</p></sec><sec><title>Results</title><p>Results. Monofactorial analysis showed that the most significant factors of inhospital and long-term mortality in ACS and KD patients after PCI were congestive heart failure, stroke, myocardial infarction anamnesis, acute heart failure (AHF), hyperglycemia, prominent systolic dysfunction of myocardium, tachicardia and hypotension at admittance, multivessel disease, as acute kidney injury (AKI) developed during hospitalization (criteria RIFLE and AKIN). Step-by-step selection in Cox regression showed that the factors of in-hospital mortality were anamnesis of stroke, AHF at admittance, AKI development during hospitalization. C-statistics of the developed model was 0,82, that is seriously more significant than that of GRACE 2,0-0,74 score. In the analysis of long-term survival by Cox, it was revealed that stroke and myocardial infarction anamnesis, as AHF at admittance and AKI regardless of other factors, are related to the increase of fatal outcomes rate during one and three years of observation. Also, the area under ROC of the invented risk models was 0,84 and 0,76, respectively, for 1 and 3 years. In GRACE 2,0 such parameter was more significantly lower — 0,78 and 0,69, respectively.</p></sec><sec><title>Conclusion</title><p>Conclusion. The results witness on the significance of additional risk factors introduction into risk assessment in patients with ACS and baseline KD, and the developed novel models were better than GRACE.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>факторы риска</kwd><kwd>острый коронарный синдром</kwd><kwd>почечная дисфункция</kwd><kwd>чрескожное коронарное вмешательство</kwd></kwd-group><kwd-group xml:lang="en"><kwd>risk factors</kwd><kwd>acute coronary syndrome</kwd><kwd>renal dysfunction</kwd><kwd>percutaneous coronary intervention</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Strel’chenko OV, Chernyshev VM, Mingazov IF. Key indicators of the Siberian Federal District public health and health care in 2014. The collection of statistical and analytical materials. Release 14. Novosibirsk: Sibirskoe universitetskoe izdatel’stvo, 2015. p. 270. (InRuss.) Стрельченко О.В., Чернышев В.М., Мингазов И.Ф. Основные показатели здоровья населения и здравоохранения Сибирского федерального округа в 2014 году. Сборник статистических и аналитических материалов. Выпуск 14. Новосибирск: Сибирское университетское издательство, 2015. с. 270.</mixed-citation><mixed-citation xml:lang="en">Strel’chenko OV, Chernyshev VM, Mingazov IF. Key indicators of the Siberian Federal District public health and health care in 2014. The collection of statistical and analytical materials. Release 14. Novosibirsk: Sibirskoe universitetskoe izdatel’stvo, 2015. p. 270. (InRuss.) Стрельченко О.В., Чернышев В.М., Мингазов И.Ф. Основные показатели здоровья населения и здравоохранения Сибирского федерального округа в 2014 году. Сборник статистических и аналитических материалов. Выпуск 14. Новосибирск: Сибирское университетское издательство, 2015. с. 270.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bawamia B, Mehran R, Qiu W, et al. Risk scores in acute coronary syndrome and percutaneous coronary intervention: a review. American Heart Journal 2013; 165 (4): 441-50.</mixed-citation><mixed-citation xml:lang="en">Bawamia B, Mehran R, Qiu W, et al. Risk scores in acute coronary syndrome and percutaneous coronary intervention: a review. American Heart Journal 2013; 165 (4): 441-50.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Zykov MV, Barbarash OL, Zykova DS, et al. Comparative characteristics of scales predicting hospital mortality in patients with myocardial infarction. Russian Journal of cardiology 2012; 1: 11-6. (In Russ.) Зыков М.В., Барбараш О.Л., Зыкова Д.С. и др. Сравнительная характеристика шкал прогнозирования госпитальной летальности у больных инфарктом миокарда. Российский кардиологический журнал 2012; 1: 11-6.</mixed-citation><mixed-citation xml:lang="en">Zykov MV, Barbarash OL, Zykova DS, et al. Comparative characteristics of scales predicting hospital mortality in patients with myocardial infarction. Russian Journal of cardiology 2012; 1: 11-6. (In Russ.) Зыков М.В., Барбараш О.Л., Зыкова Д.С. и др. Сравнительная характеристика шкал прогнозирования госпитальной летальности у больных инфарктом миокарда. Российский кардиологический журнал 2012; 1: 11-6.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Roffi M, Patrono C, Collet JP, et al. 204. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal 2016; 37: 267-315.</mixed-citation><mixed-citation xml:lang="en">Roffi M, Patrono C, Collet JP, et al. 204. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal 2016; 37: 267-315.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291 (22): 2727-33.</mixed-citation><mixed-citation xml:lang="en">Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291 (22): 2727-33.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kellum JA, Aspelin P, Barsoum RS, et al. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements 2012; 2 (1): 1-138.</mixed-citation><mixed-citation xml:lang="en">Kellum JA, Aspelin P, Barsoum RS, et al. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements 2012; 2 (1): 1-138.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fox KA, FitzGerald G, Puymirat E, et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ 2014; 4 (2): e004425.</mixed-citation><mixed-citation xml:lang="en">Fox KA, FitzGerald G, Puymirat E, et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ 2014; 4 (2): e004425.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Fox КА, Dabbous ОН, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006; 333 (7578): 1091-4.</mixed-citation><mixed-citation xml:lang="en">Fox КА, Dabbous ОН, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006; 333 (7578): 1091-4.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Palmerini T, Genereux P, Caixeta A, et al. A new score for risk stratification of patients with acute coronary syndromes undergoing percutaneous coronary intervention: the ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy-Percutaneous Coronary Intervention) risk score. JACC Cardiovasc Imaging 2012; 5 (11): 1108-16.</mixed-citation><mixed-citation xml:lang="en">Palmerini T, Genereux P, Caixeta A, et al. A new score for risk stratification of patients with acute coronary syndromes undergoing percutaneous coronary intervention: the ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy-Percutaneous Coronary Intervention) risk score. JACC Cardiovasc Imaging 2012; 5 (11): 1108-16.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lev EI, Kornowski R, Vaknin-Assa H, et al. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. American Journal of Cardiology 2008; 102 (1): 6-11.</mixed-citation><mixed-citation xml:lang="en">Lev EI, Kornowski R, Vaknin-Assa H, et al. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. American Journal of Cardiology 2008; 102 (1): 6-11.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Abu-Assi E, Ferreira-Gonzalez I, Ribera A, et al. Do GRACE (Global Registry of Acute Coronary Events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes? American Heart Journal 2010; 160 (5): 826-34.</mixed-citation><mixed-citation xml:lang="en">Abu-Assi E, Ferreira-Gonzalez I, Ribera A, et al. Do GRACE (Global Registry of Acute Coronary Events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes? American Heart Journal 2010; 160 (5): 826-34.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Shiraishi J, Kohno Y, Nakamura T, et al. Prognostic impact of chronic kidney disease and anemia at admission on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. International Heart Journal 2014; 55: 301-6.</mixed-citation><mixed-citation xml:lang="en">Shiraishi J, Kohno Y, Nakamura T, et al. Prognostic impact of chronic kidney disease and anemia at admission on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. International Heart Journal 2014; 55: 301-6.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Van der Meer IM, del Sol AI, Hak AE, et al. Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: The Rotterdam Study. Stroke 2003; 34: 2374-9.</mixed-citation><mixed-citation xml:lang="en">Van der Meer IM, del Sol AI, Hak AE, et al. Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: The Rotterdam Study. Stroke 2003; 34: 2374-9.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Morikami Y, Natsuaki M, Morimoto T, et al. Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: an observation from the CREDO-Kyoto Registry Cohort-2. Atherosclerosis 2013; 228 (2): 426-31.</mixed-citation><mixed-citation xml:lang="en">Morikami Y, Natsuaki M, Morimoto T, et al. Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: an observation from the CREDO-Kyoto Registry Cohort-2. Atherosclerosis 2013; 228 (2): 426-31.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Barbarash OL, Zykov MV, Bykova IS, et al. Role of Renal Dysfunction and Multifocal Atherosclerosis in Assessment of Prognosis of Patients Presenting With ST-Elevation Acute Coronary Syndrome. Kardiologija 2013; 53 (9): 26-32. (In Russ.) Барбараш О.Л., Зыков М.В., Быкова И.С. и др. Роль дисфункции почек и мультифокального атеросклероза в оценке прогноза у больных инфарктом миокарда с подъемом сегмента ST. Кардиология 2013; 53 (9): 26-32.</mixed-citation><mixed-citation xml:lang="en">Barbarash OL, Zykov MV, Bykova IS, et al. Role of Renal Dysfunction and Multifocal Atherosclerosis in Assessment of Prognosis of Patients Presenting With ST-Elevation Acute Coronary Syndrome. Kardiologija 2013; 53 (9): 26-32. (In Russ.) Барбараш О.Л., Зыков М.В., Быкова И.С. и др. Роль дисфункции почек и мультифокального атеросклероза в оценке прогноза у больных инфарктом миокарда с подъемом сегмента ST. Кардиология 2013; 53 (9): 26-32.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">KalaevaVV, KaretnikovaVN, ZykovMV, etal. Risk factors of contrast-induced nephropathy in patients with myocardial infarction. Klinicheskaja medicina 2014; 92 (9): 39-45. (In Russ.) Калаева В.В., Каретникова В.Н., Зыков М.В. и др. Факторы риска контрастиндуцированной нефропатии у больных инфарктом миокарда. Клиническая медицина 2014; 92 (9): 39-45.</mixed-citation><mixed-citation xml:lang="en">KalaevaVV, KaretnikovaVN, ZykovMV, etal. Risk factors of contrast-induced nephropathy in patients with myocardial infarction. Klinicheskaja medicina 2014; 92 (9): 39-45. (In Russ.) Калаева В.В., Каретникова В.Н., Зыков М.В. и др. Факторы риска контрастиндуцированной нефропатии у больных инфарктом миокарда. Клиническая медицина 2014; 92 (9): 39-45.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
